Researchers from Finland worked with startup Valkee to unveil a bright light headset to treat seasonal affective disorder in 2010. Now it's released placebo-controlled, randomized data about jet lag reduction for its CE-marked headset dubbed the HumanCharger.
China Medical Systems Holding has licensed Greater China rights to develop and commercialize Finland's Faron Pharmaceuticals' Traumakine (FP-1201), a recombinant human interferon (IFN) beta-1a to treat severe and acute respiratory distress syndrome.
GE Healthcare has opened its first health tech startup campus at its Finland headquarters in Helsinki. It's already home to 20 health tech startups working on wireless technologies, sensors, apps and cloud services to improve healthcare.
If successful the trial--which is due to last two to three years--will culminate in marketing applications to U.S. and European regulators.
ArcDia has raised nearly $3.5 million (2.7 million euros) to fuel expanded use of its mariPOC diagnostic test for respiratory tract infections.
Finnish researchers found that the chance of narcolepsy was much higher in children who received a certain flu vaccine.
Pfizer's ($PFE) Israeli unit is lending a paw--actually, 8 paws--to help Finland crack down on counterfeit Viagra. Canines Springer and Willem can sniff out the top-selling erectile-dysfunction...
The World Health Organization is widening its probe of a possible link between GlaxoSmithKline's Pandemrix vaccine and narcolepsy. In an advisory panel briefing, Reuters reports, the agency said
Finland's National Institute for Health and Welfare says there is a link between GlaxoSmithKline's Pandemrix flu vaccine and a spike in narcolepsy cases. Narcolepsy is a disorder that causes a person